CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Ticagrelor

Ticagrelor

Product Description

Ticagrelor (API) is an antiplatelet medicine.

Shanghai Huilun Pharmaceutical Co., Ltd.

Shanghai Huilun Pharmaceutical Co., Ltd.

Country/Region:

China
On CPHI since:

2022
Employees:

1000 - 4999

Company types

Manufacturer/Innovator

Compare Add to favorites Added to favorites

Categories

Anatomical Therapeutic Chemical (ATC) Classification Products Cardiovascular System

Specifications

CAS Registry Number

274693-27-5
Details

EP
Selling Points
Cardiovascular Health
Supplied from

China
Measured In
kilogram

Sales Markets

East Asia (e.g. China, Japan, Korea)
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
South Asia (e.g. India, Pakistan, Sri Lanka)

Shanghai Huilun Pharmaceutical Co., Ltd.

Shanghai Huilun Pharmaceutical Co., Ltd.

Country/Region:

China
On CPHI since:

2022
Employees:

1000 - 4999

Company types

Manufacturer/Innovator

Compare Add to favorites Added to favorites

More Products from Shanghai Huilun Pharmaceutical Co., Ltd. (2)

Product Cabozantinib

Cabozantinib is used to treat kidney, liver and thyroid cancers that have spread to other parts of the body.

Compare
Product Silodosin

Silodosin (API) is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia; BPH).

Compare